Navigation Links
FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
Date:4/24/2008

CINCINNATI and BRIDGEWATER, N.J., April 24 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel(R) (risedronate sodium) tablets for the treatment and prevention of postmenopausal osteoporosis. Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis.

The FDA approval of the once-a-month dose is based on a study comparing Actonel 150 mg once monthly to Actonel 5 mg daily. Similar increases in bone mineral density (BMD) were seen among patients taking either once-a-month or daily dosing regimens.

Over fifty-five million prescriptions of Actonel have been filled in the U.S. alone since its approval for osteoporosis in 2000. Those who want to learn more about postmenopausal osteoporosis and treatment with Actonel should visit: http://www.Actonel.com.

About Osteoporosis

Postmenopausal osteoporosis is a silent disease that affects millions of women, making their bones weak and more likely to fracture over time. In fact, in the U.S. today, 8 million women are estimated to already have osteoporosis, and almost 27 million more are estimated to have low bone mass, placing them at increased risk for fracture. Each year the incidence of osteoporosis-related fractures is greater than the incidence of heart attacks, strokes, and breast cancer combined. The good news is that there are prescription medications available that effectively reduce fractures.

About Actonel

Actonel is contraindicated in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. Hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for use in patients with severe renal impairment (creatinine clearance < 30 mL/min).
'/>"/>

SOURCE The Alliance for Better Bone Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Beach, Florida (PRWEB) August 22, 2014 ... for Lasik in Fort Lauderdale at the most affordable ... get better eyesight through their advanced Lasik treatments. LASIK ... worldwide and the Braverman Eye Center has been delivering ... of patients live a glasses-free and contact lenses-free life ...
(Date:8/22/2014)... pain, breathing difficulties, fainting. Each year approx. 265,000 Danes ... serious illness. New research from Aarhus University and Aarhus ... as many as every fourth patient are sent ... symptoms that led to the acute hospitalisation., "Naturally, there ... at the hospital disprove that there is a serious ...
(Date:8/22/2014)... new study from Karolinska Institutet in Sweden provides insight ... touch, vision or sound from different sources and sides ... adequate movements. The findings, which are presented in the ... as a sensory ,hub, integrating various types of sensory ... types. , "The striatum is the main input structure ...
(Date:8/22/2014)... allergy is frequently confused with lactose intolerance. However, these ... body. People with lactose intolerance do not digest lactose ... In the case of the potentially much more dangerous ... milk proteins with its own IgE antibodies. , According ... in Europe suffer from a genuine milk allergy. Less ...
(Date:8/22/2014)... be able to better understand their risks of future ... with different treatments. , The findings, set out in ... are based on the experience of more than 2,000 ... cancer over a period of more than 40 years. ... lymphoma who receive certain types of chemotherapy or radiotherapy ...
Breaking Medicine News(10 mins):Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2Health News:Many patients are discharged without a diagnosis 2Health News:The striatum acts as hub for multisensory integration 2Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... Support the Long Term Mental Health Needs ... SAN DIEGO, Oct. 24 As the hundreds of,thousands San ... what,happened and deal with the stress of the situation. These ... those directly and,indirectly affected. In the days, weeks and months ...
... Support The Cause In A Variety Of Ways ..., ... the,team,s First Annual Breast Cancer Awareness Night on Friday, October ... Joe Louis Arena. Doors open,at 6 p.m. for the 7:30 ... Hockey Fights Cancer month when all NHL players wore special ...
... MONTREAL, Oct. 24 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX ... to,announce a new two-phase strategy to have a ... for its lead product candidate, the,Hemaseel(R)HMN fibrin sealant, ... This "First-Patient-In" objective is a major milestone ...
... M. Foley, MD,of Memorial Sloan-Kettering Cancer Center in ... University of Utah School of Medicine, received the ... 2007 at the 9th,Annual Josefina Magno Conference on ... of palliative care, the science of pain and,symptom ...
... reduced toxicity, studies find, , , WEDNESDAY, Oct. 24 (HealthDay ... to the standard two-drug regimen used for head and ... reducing the toxicity, two new studies report. , The ... increased survival in both studies and more than doubled ...
... Norway October 24, 2007 - The use of ... increased incidence of reproductive endocrine disorders in both men ... the effects of withdrawal from two common AEDs, carbamazepine ... and female AED users. , The study finds ...
Cached Medicine News:Health News:San Diego Wildfires Mental Health Fund 2Health News:San Diego Wildfires Mental Health Fund 3Health News:Red Wings Host Breast Cancer Awareness Night 2Health News:Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials 2Health News:Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials 3Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 3
(Date:8/22/2014)... , August 22, 2014 ... Hospital TVs Today Lincor announced general availability ... Engagement solution that delivers a range of education, entertainment ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , ... defining point of care patient engagement to bedside smart ...
(Date:8/22/2014)... -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the pricing ... stock and warrants at a price of $10,000 per ... deducting underwriting discounts and commissions and offering expenses payable ... separable and will be issued separately.  The shares of ... NASDAQ Stock Market under the ticker symbol "WGBS" on ...
(Date:8/21/2014)... , Aug. 21, 2014 Nektar ... International Inc. today announced positive results from its ... an investigational, extended half-life recombinant factor VIII (rFVIII) ... Factor (Recombinant)], which met its primary endpoint in ... arm compared to the on-demand arm. ...
Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... New Jersey, May 31, 2012 The Dueling Pianos ... th . The event is slated 6.30 pm onwards and promises ... Pianos, based out of the Philly area since March of 1990, ... the east coast, from Boston to North Carolina, out to Anaheim, ...
...  Just days after the Senate overwhelming approved legislation to better ... followed suit, passing the Food and Drug Administration Reform ... The Bulk Pharmaceuticals Task Force (BPTF), an affiliate ... (SOCMA), welcomed the vote and urged House and Senate conferees ...
Cached Medicine Technology:SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos 2SOCMA's Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act 2
... WatchMate system is designed to protect a ... and becoming lost or injured. Such residents ... etc., or have suffered a head injury., ... on their wrist or ankle, and points ...
... Smart™ Labels have a direct thermal ... Instruments Tag-it™ HF-I transponder. When processed ... text and other graphics may be ... data is programmed to the RFID ...
... a patent pending solution using Radio ... a smart label to promote patient ... wrong-site, wrong-procedure surgery. This simple to ... orthopedic surgeon with the operating room ...
... Hospitals, correctional facilities, recreational venues ... wristbands to provide automated data capture ... reducing costly and dangerous errors. RFID ... admissions wristbands at entertainment venues as ...
Medicine Products: